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Abstract
Human T-lymphotropic virus type-1 (HTLV-1) persists within hosts via infectious spread (de
novo infection) and mitotic spread (infected cell proliferation), creating a population structure
of multiple clones (infected cell populations with identical genomic proviral integration sites).
The relative contributions of infectious and mitotic spread to HTLV-1 persistence are
unknown, and will determine the efficacy of different approaches to treatment. The prevail-
ing view is that infectious spread is negligible in HTLV-1 persistence beyond early infection.
However, in light of recent high-throughput data on the abundance of HTLV-1 clones, and
recent estimates of HTLV-1 clonal diversity that are substantially higher than previously
thought (typically between 104 and 105 HTLV-1+ T cell clones in the body of an asymptom-
atic carrier or patient with HTLV-1-associated myelopathy/tropical spastic paraparesis),
ongoing infectious spread during chronic infection remains possible. We estimate the ratio
of infectious to mitotic spread using a hybrid model of deterministic and stochastic pro-
cesses, fitted to previously published HTLV-1 clonal diversity estimates. We investigate the
robustness of our estimates using three alternative estimators. We find that, contrary to pre-
vious belief, infectious spread persists during chronic infection, even after HTLV-1 proviral
load has reached its set point, and we estimate that between 100 and 200 new HTLV-1
clones are created and killed every day. We find broad agreement between all estimators.
The risk of HTLV-1-associated malignancy and inflammatory disease is strongly correlated
with proviral load, which in turn is correlated with the number of HTLV-1-infected clones,
which are created by de novo infection. Our results therefore imply that suppression of de
novo infection may reduce the risk of malignant transformation.
Author summary
There is no effective antiretroviral treatment for infection with Human T-lymphotropic
virus type-1 (HTLV-1), which causes a range of inflammatory diseases and the aggressive
malignancy Adult T-cell Leukaemia/Lymphoma (ATL) in approximately 10% of infected
people. Within hosts the virus spreads via infectious spread (de novo infection) and
PLOS COMPUTATIONAL BIOLOGY







Citation: Laydon DJ, Sunkara V, Boelen L,
Bangham CRM, Asquith B (2020) The relative
contributions of infectious and mitotic spread to
HTLV-1 persistence. PLoS Comput Biol 16(9):
e1007470. https://doi.org/10.1371/journal.
pcbi.1007470
Editor: Roland R. Regoes, ETH Zurich,
SWITZERLAND
Received: October 4, 2019
Accepted: July 31, 2020
Published: September 17, 2020
Copyright: © 2020 Laydon et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files. Model code is provided at https://
github.com/dlaydon/HTLV_1_InfMit_Hybrid.
Funding: DJL acknowledges grant funding from
the Bill and Melinda Gates Foundation, joint Centre
funding from the UK Medical Research Council and
Department for International Development (grant
MR/R015600/1), the Wellcome Trust (Project
Grant 091845 to CRMB, BA; Senior Investigator
Award 100291 to CRMB), and the Imperial College
mitotic spread (infected cell division). The relative contributions of each mechanism are
unknown, and have major implications for drug development and clinical management
of infection. We estimate the ratio of infectious to mitotic spread during the infection’s
chronic phase using three methods. Each method indicates infectious spread at low but
persistent levels after proviral load has reached set point, contrary to the prevailing view
that infectious spread features in early infection only. Risk of disease in HTLV-1 infection
is known to increase with proviral load, via mutations accrued from repeated infected cell
division. Our analyses suggest that ongoing infectious spread may provide an additional
mechanism whereby chronic infection becomes malignant. Further, because antiretroviral
drugs against Human Immunodeficiency Virus (HIV) inhibit HTLV-1 infectious spread,
they may reduce the risk of HTLV-1 malignancy.
Introduction
Human T-lymphotropic virus type-1 (HTLV-1), also known as the human T cell leukaemia
virus, infects an estimated 10 million people worldwide [1]. While the majority of infected
individuals remain lifelong asymptomatic carriers (ACs), in ~10% the virus causes either
Adult T-cell Leukaemia/Lymphoma (ATL) [2] or a range of chronic inflammatory diseases,
notably a disease of the central nervous system called HTLV-1-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) [3]. HTLV-1 viral burden is quantified by the proviral load
(PVL), defined as the number of HTLV-1 proviruses per 100 peripheral blood mononuclear
cells (PBMCs). During the chronic phase of infection, PVL remains approximately constant
within each host [4, 5], but varies between hosts by over four orders of magnitude; a high PVL
is associated with HAM/TSP [5, 6] and ATL [7].
HTLV-1 replicates in the host through two pathways: mitotic spread and infectious spread
[8]. In mitotic spread, an infected cell divides to produce two identical “sister cells" which
carry the single-copy provirus, integrated in the same genomic location as the parent cell.
Infectious spread, or de novo infection, occurs when the virus infects a previously uninfected
cell, and in this case the virus integrates in a new site in the target cell genome (Fig 1). The
combination of infectious and mitotic spread results in a large number of distinct clones of
infected T-cells, where each clone is defined as a population of infected cells with a shared pro-
viral integration site [9–11].
The relative contributions of infectious spread and mitotic spread to the proviral load are
unknown. This ratio is important, because it will directly determine the efficacy of different
approaches to treatment. Although no effective antiretroviral drugs have yet been developed
for HTLV-1 infection, antiretroviral therapy (ART) efficiently reduces infectious spread in
HIV-1 infection by inhibiting reverse transcription, viral maturation and proviral integration.
ART may therefore be effective in HTLV-1 infection if infectious spread contributes to HTLV-
1 pathogenesis. Alternatively, drugs that inhibit T cell proliferation, such as cyclosporin, would
be expected to be more useful if mitotic spread [8] is the dominant mode of viral spread.
The number of clones of HTLV-1-infected T cells depends on the extent of infectious
spread. In this paper, we refer to this number as the HTLV-1 clonal “diversity" (this term
should not be confused with measures such as Shannon entropy or beta diversity). The diver-
sity in one host is unknown, and estimating this number from blood samples is nontrivial.
Diversity estimation is challenging given the nature of the HTLV-1 clone frequency distribu-
tion, where the majority of infected cells are contained in relatively few clones, and the major-
ity of clones contain relatively few cells.
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The prevailing view is that mitotic spread accounts for the long-term persistence of HTLV-
1 in vivo [11–14], and that infectious spread is negligible after initial infection [12, 13]. This
belief was supported by three main observations. First, it was thought that there were relatively
few (~100) HTLV-1 clones in one host [9, 11, 13, 15–19]. Second, HTLV-1 varies little in
sequence both within and between hosts [20]. Since the host DNA polymerase used in cell pro-
liferation (mitotic spread) is far less error-prone than the viral reverse transcriptase used in
infectious spread, a lack of sequence variation implies that infectious spread is rare. Third,
many HTLV-1+ clones have been observed at multiple time points separated by several years
[9, 17], and a long-lived clone is very unlikely to be maintained by repeated proviral integra-
tion at the same integration site through infectious spread, especially since there are no hot-
spots of HTLV-1 integration [9].
However, these three observations do not necessarily imply that infectious spread is negligi-
ble in HTLV-1 pathogenesis [14], particularly when we consider the total number of clones in
the host and the very small proportion of clones that can be sampled. First, the number of
clones that have been both estimated and directly observed has increased over time [9, 11, 13,
15, 17, 19], and current estimates give approximately 104–105 clones in the circulation of ACs
and patients with HAM/TSP [10, 21, 22]. Because smaller and smaller clones can be detected
as method sensitivity increases, it is no longer a given that all clones are large and thus that
infectious spread is non-existent during chronic infection. Second, apparent sequence unifor-
mity may result from repeated detection of sister cells from a small number of expanded
clones. That is, because of the limitations of sampling, there is a strong bias to detection of the
large clones which have expanded through mitosis. Third, the repeated observation of specific
clones over many years does not rule out persistent infectious spread. The observation of a
temporary but dramatic PVL reduction in a patient with HAM/TSP following treatment with
the reverse transcriptase inhibitor lamivudine [23] implies that infectious spread could remain
Fig 1. HTLV-1 infectious and mitotic spread schematic. Left column (Infectious spread): an HTLV-1-infected cell
infects an uninfected CD4+ T cell (typically by cell-to-cell contact via the virological synapse, and potentially also via
cell-free spread). The HTLV-1 provirus (red) integrates in a different genomic location in the newly infected cell, so
infectious spread has resulted in two clones. Right column (Mitotic spread): An HTLV-1-infected cell divides,
whereupon the provirus resides in the same genomic location in each daughter cell. The figure shows a single clone
with two HTLV-1-infected cells.
https://doi.org/10.1371/journal.pcbi.1007470.g001
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important in HTLV-1 persistence, at least in some cases. Finally, the virus must retain the
capacity for infectious spread, for the simple reason that it could not spread between hosts oth-
erwise. We therefore believe it is right to question the assumption that all clones are formed
during early infection.
Mitotic spread must still be predominant in proviral load maintenance, however, because
the 104–105 clones (created by infectious spread) present in one host consist of approximately
1011 infected cells (created by mitotic spread). However, this consideration ignores the possi-
bility that clones may be continuously created by infectious spread and killed by the immune
response and natural death.
The aim of this study was to quantify the rate of infectious spread, and thus the ratio of
infectious spread to mitotic spread during chronic infection. We first estimated HTLV-1
clonal diversity from sequence data in 11 subjects using our previously developed method
[10]. We next fitted a deterministic and stochastic hybrid model of within-host HTLV-1 per-
sistence to clonal diversity estimates. To ensure the robustness of our estimates, we used three
alternative estimators of the infectious spread rate, the first of which approximates the upper
bound of the infectious spread rate using a simplified model of HTLV-1 clones. The final two
estimators are adapted from a method originally developed to model naïve T cell dynamics.
We find broad agreement between estimates from all methods. We conclude that, during
chronic infection, a given HTLV-1-infected cell in the peripheral blood is substantially more
likely to be derived by mitosis of an existing clone than by de novo infection, although infec-




We apply all three methods described below to previously obtained high-throughput data on
HTLV-1 clonality [9]. Each HTLV-1 dataset quantifies the abundance of HTLV-1-infected T
cell clones in ex vivo PBMCs, without selection or culture. We studied 11 subjects, where each
subject had three blood samples taken per time point, at three time points separated by an
average of 4 years, giving a total of 99 datasets. All subjects either had HAM/TSP, HTLV-
1-associated uveitis or were asymptomatic carriers of HTLV-1.
HTLV-1 clonal diversity estimates
To estimate the rate of infectious spread we first estimated HTLV-1 clonal diversity. We use our
recently developed estimator, “DivE" [10, 24, 25], which uses experimental observations of
clonal diversity in a sample to estimate both the number of clones and their frequency distribu-
tion in the body of the host (Fig 2A). DivE fits multiple mathematical models to individual-
based rarefaction curves; such curves plot the expected number of clones against the number of
infected cells sampled. Numerical criteria score models on their ability to accurately estimate
the observed rarefaction curve when fitted to nested subsamples of the data. The best-perform-
ing models are extrapolated to estimate the total number of clones in the body, based on the
proviral load in each respective subject. See [10, 25] for further details and implementation.
S2 Table gives the notation used in the three modelling approaches that follow.
Modelling approach 1: Full simulation hybrid model
Within a given host, HTLV-1+ T cell clones vary in abundance by several orders of magnitude
[9, 10]. Broadly, abundant clones can be modelled deterministically but small clones must be
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modelled stochastically. In the following sections, we describe a model of HTLV-1 dynamics at
quasi-equilibrium that is a hybrid of deterministic and stochastic parts (Fig 2).
Deterministic model
We consider a system with S(t) clones, where a given clone i has frequency xi(t) at time t. We










xjðtÞ is the total number of infected cells summed over all clones at time t;
p
KþNðtÞ is the proliferation rate of infected cells (i.e. the rate of mitotic spread) which is half maxi-
mal when N(t) = K (S1 Text) and δ is the death rate of infected cells (Fig 2B). New clones
appear at a rate rI × N(t), where rI is the per-capita rate of infectious spread. Note that we make
the simplifying approximation of a single proliferation rate, pKþNðtÞ, for all clones.
The dynamics of small clones, where random effects are important, will not be adequately
described by a deterministic model. Since small clones contain most information about infec-
tious spread, it is important to model these clones accurately, and so we use a discrete stochas-
tic model, in which we consider multiple potential states of each clone and their
corresponding probabilities over time.
Stochastic model
Using a stochastic framework, the number of clones S(t) and their frequencies at time t are
considered as random variables, and we describe within-host HTLV-1 dynamics by a set of
reactions and their corresponding propensities (S2 Text). Infected cells can proliferate, die, or
infect uninfected cells (Fig 1). Thus the total number of possible reactions C 2 N at time t is
Fig 2. Schematic of full simulation hybrid model. A: Observed and estimated clone frequency distributions. From an observed sample of clones, the clone frequency
distribution of the body in one host is estimated using DivE. B: Propagation of hybrid model: Estimated clone frequency distribution partitioned into deterministic and
stochastic systems. Clones of frequency less than and greater than threshold F are respectively modelled stochastically and deterministically. F is chosen with respect to
probability of clone extinction (S2 Text). The deterministic system is modelled using ordinary differential equations (Eq (1)). The stochastic system consists of multiple
birth-death processes (one for each stochastically modelled clone) each with an absorbing state at zero (Fig 3A and 3B). The evolution of the clone probability
distribution over time is governed by the chemical master equation (Eq (10), Fig 3C and 3D). New clones are created through infectious spread, i.e. the per-capita rate rI
multiplied by the expected number of infected cells, in both deterministic and stochastic compartments (Eq (11)). Deterministic and stochastic systems are propagated
concurrently with Strang splitting (S2 Text). C: Hybrid model diversity. The estimated number of clones S(t) (Eq (13)) at time t, given parameters θ = {π, δ, K, rI} is given
by the number of clones created (Eq (11)), minus the number of clones that are expected to have died between 0 and t (Eq (12)), plus the number of clones S0 at t = 0.
The number of clones is assumed to be at equilibrium in the chronic phase of infection. D: Model fitting schematic: Expected diversity at S(tDur) increases with per-
capita infectious spread rate rI. Model fitted using non-linear least squares to DivE estimated diversity in the body, where the objective function is the square of the
discrepancy between this value and the value of S(tDur) at equilibrium.
https://doi.org/10.1371/journal.pcbi.1007470.g002
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C = 3S(t). Following the formulation given in [26, 27], let X(t) = (Xi(t)i2S(t))T be the state vector
at time t of all clones. X(t) is a random variable in NSmax that consists of the random variables
XiðtÞ 2 N0 ¼ N [ f0g of the frequencies xi(t) of clones i = 1,. . ., Smax, where Smax is chosen to
always be larger than S(t) for all t. The state vector X(t) evolves through a Markov jump process
that depends only on the current state y 2 NSmax
0
, and its evolution is given by







where νc and αc respectively denote the stoichiometric vector and propensity function of reac-
tion c [26, 27]. Eq (2) states that the population X(t) at time t is equal to the initial population
y0 plus the sum of the changes induced by all reactions. See S2 Text for further details.
There exists a probability distribution associated with the random variable XðtÞ 2 NSmax
0
in
(2), given by PðX; tÞ ¼ PðXðtÞ ¼ yjXð0Þ ¼ y0Þ, where y; y0 2 N
Smax
0
. PðX; tÞ is a column vector
where each entry is a probability associated with a potential state of the random variable at
time t. It can be shown [27–30] that PðX; tÞ is a solution of the Chemical Master Equation
(CME)





ðacðy   ncÞPðX ¼ y   nc; tÞ   acðyÞPðX ¼ y; tÞÞ ð3Þ
which describes the rate of change in the probability distribution associated with X(t). The first
term is the sum over all reactions of the probability of arriving at state X(t) = y from state X(t)
= y—νc via reaction c, and the second term is the sum over all reactions of the probability of
leaving state X(t) = y via reaction c.
For a single clone X i, the following reactions respectively describe mitotic spread, cell death
and infectious spread:
ri;1 : X i!
p�ðtÞ
2X i ð4Þ
ri;2 : X i!
d
� ð5Þ
ri;3 : X i!






is the aggregate density-dependent proliferation rate (dependent on the carrying capacity, and
the numbers of infected and uninfected cells). The first two reactions of each clone describe a
birth-death process, and the lack of inflow from source (i.e. the lack of a reaction r : � ! X i)
defines an absorbing state (Fig 3A and 3B). Note that Eq (6) makes the approximation that all
instances of infectious spread lead to a new clone. Any errors from this assumption will be
small, and this is considered in greater detail in the Discussion.
The reactions (4), (5) and (6) are monomolecular (in terms of the chemical master equa-
tion), because they carry the simplifying assumption that cell death due to the host immune
response, and the proviral load, are each constant in the equilibrium within each host. HTLV-
1 proviral load remains stable over many years [4, 5]: that is, the numbers of infected and unin-
fected cells stays approximately constant during the chronic phase of infection.
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Simplifying approximations of stochastic model
The probability distribution PðX; tÞ describes the states and associated probabilities of the
entire system, and we define the probability distribution of a particular clone i, PðXi; tÞ associ-
ated with the random variable Xi(t) similarly: PðXi; tÞ ¼ PðXiðtÞ ¼ xijXið0Þ ¼ xi;0Þ, where
xi; xi;0 2 N0. The extinction probability of clone i at time t, PðXi ¼ 0; tÞ, is used below to calcu-
late the expected number of clones at time t (Fig 2C), which in turn enables the model to be fit-
ted to clonal diversity estimates (Fig 2D).
If clones interact and are modelled with a single master equation associated with PðX; tÞ,
the complexity and runtime of the model increase exponentially with the number of clones.
However, because we model the system when proviral load is in equilibrium and can therefore
use monomolecular reactions, density-dependent proliferation rates remain approximately
constant, and so we can model each clone in isolation with multiple master equations associ-
ated with multiple clone-specific distributions PðXi; tÞ (i = 1, . . ., S(t)) (Fig 2B). Therefore, the
model complexity and runtime increase only linearly with the number of clones.
Fig 3. Stochastic clone dynamics. A and B respectively show the clone state space with and without an upper limit τ. Each box denotes the potential state of a given
clone, i.e. the number of cells in that clone, with the corresponding propensity of each reaction at each state. π�(t) and δ denote the per-capita rates of infected cell
proliferation and death respectively. Note there is no source inflow from frequency 0 to frequency 1. C and D show clone frequency probability distributions over
time. Each curve shows the distribution PðXi; tÞ ¼ PðXiðtÞ ¼ xijXið0Þ ¼ xi;0Þ of the probability that the given clone i contains xi cells at time t. At successive time
points the curve broadens and either shifts to the right as the expected frequency of the clone increases (C), or shifts to the left as the expected frequency of the clone
decreases (D).
https://doi.org/10.1371/journal.pcbi.1007470.g003
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If we impose a maximum frequency for a particular clone i (S2 Text, Fig 3B), we can sum-
marise Eq (3) using multiple, simpler differential equations below
dPðXi; tÞ
dt
¼ APðXi; tÞ for i ¼ 1; . . . ; Smax ð8Þ
where A is the transition matrix or “matrix of connections" (S2 Text) [27, 31, 32]. Further,
because the proliferation rate is constant at equilibrium, rates are independent of time, and so
Eq (8) has solution
PðXi; tÞ ¼ eAtP0;i ð9Þ
where P0;i ¼ PðXi; t ¼ 0Þ is the initial probability distribution and e
At is the matrix exponential
[33]. For equally spaced time steps ðtnÞ
N
n¼0 of length h, PðXi; tÞ can be calculated recursively
PðXi; tnÞ ¼ eAhPðXi; tn  1Þ: ð10Þ
Example solutions of Eq (9) are shown in Fig 3C and 3D.
Expected number of clones
We model the expected number of clones S(t) at time t by adding the total number of clone
“births” b(t) over time (that is, the number of infectious spread events), and subtracting the












where rI is the per-capita rate of infectious spread, xj(t) is the expected frequency of the jth




PðXj ¼ 0; tÞ ð12Þ
Note that b(t) and E(t) are increasing functions since rI, xj(t)� 0, and because a clone fre-
quency of zero is an absorption state for the random variable Xj(t). Taking (11) and (12)
together we calculate the number of clones S(t) as
SðtÞ ¼ S0 þ bðtÞ   EðtÞ ð13Þ
where S0 is the number of clones at time zero (Fig 2C).
Eq (11) does not have a density-dependent rI, and so for large values of the number of new
clones and cells would tend to infinity over time. Practically, however, rI is sufficiently small
that it was unnecessary to add density-dependent de novo infection to the model.
Hybrid model fitting and uncertainty
It is estimated that there are approximately 1011 HTLV-1 infected cells in one host [10], and so
it is not computationally feasible to model all clones using our stochastic formulation. Clones
above a certain frequency [F = 460 cells; S2 Text] are assumed to be adequately described by
the expected value from the deterministic ODEs in Eq (1) (Fig 2B, 2C and 2D). We thus parti-
tion our system of HTLV-1 within-host dynamics into a deterministic system of ODEs, and a
stochastic system of master equations (Fig 2B). We propagate these systems alternatively and
concurrently using “Strang splitting" (S2 Text) [34]. The deterministic system described in Eq
PLOS COMPUTATIONAL BIOLOGY Ratio of infectious to mitotic spread in HTLV-1 persistence
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(1) has an ordinary differential equation for each clone. Since S(t) can exceed 105, we group
clones into categories based on the order of magnitude of their abundance.
We model the dynamics of clones in the body, and not only the blood, because this allows
us to model clone extinction. If zero cells of a particular clone are observed or estimated in the
blood, this does not necessarily imply that the clone is extinct, because cells in that clone could
remain in the solid lymphoid tissue, which contains 98% of lymphocytes. We model clones in the
body as a whole to avoid this difficulty, which necessitates the assumption that the clonal popula-
tion structure in the blood is representative of the HTLV-1 clonal structure in the whole body.
We fitted the infectious spread rate rI as a free parameter, with all other parameters
(infected cell proliferation rate, death rate and density dependency) fixed using previous
results from the literature and based on each subject’s proviral load [35] (S1 Text). For each
subject sample and parameter update of rI, the model was run to reach an approximate equilib-
rium (Fig 2C). The model was fitted to the estimated clonal diversity of that subject sample, i.e.
to determine the value of rI required to keep the clonal diversity at the observed equilibrium
value (Fig 2D).
The uncertainty in the estimate of rI, the rate of infectious spread, derives from three
sources: error in model choice (both structure and numerical value of fixed parameters), error
in clonal diversity estimation, and sampling variation. Classical methods of quantifying fitted
parameter uncertainty only reflect the last source of error (i.e. they assume that the model and
the data are correct). We address the first difficulty by using three alternative models with dif-
ferent structures and parameters, and through a sensitivity analysis on the infected cell prolif-
eration and death rates (S3 Text). We address the error in diversity estimation by using
alternative clonal diversity inputs from the Chao1 estimator [36], a non-parametric diversity
(or species richness) estimator that has been widely used in many fields [37–40]. And we
address the issue of sampling variation by investigating the range of estimates provided by the
nine hybrid model fits per subject (i.e. one for each of the subject’s blood samples); the mean
of these estimates is taken as our point estimate.
The hybrid model was coded in R (version 3.5.0) [41], using the packages “data.table" [42]
and “Matrix" [43]. Matrix exponentials were computed using the Padé approximation [44].
The hybrid was fitted using one-dimensional optimisation as described in [45]. The model
code is available at https://github.com/dlaydon/HTLV_1_InfMit_Hybrid.
Modelling approach 2: Upper bound approximation
We considered a simplified model of HTLV-1 persistence that does not describe individual
clone dynamics. If S(t) and N(t) are the number of clones and number of infected cells respec-
tively at time t, and rI, is the per-capita rate of infectious spread, we have the following differen-
tial equation
S0ðtÞ ¼ rINðtÞ   dSðtÞSðtÞ ð14Þ
where δS(t) is the clone death rate at time t. The first term of Eq (14) models the birth of new
clones by infectious spread, and the second term models the death of existing clones.
If δ is the (constant) death rate of infected cells, then we have δS(t)� δ, because the number
of clones that die cannot exceed the number of cells that die (equality would occur if all clones
were singletons i.e. clones that contain only one infected cell). The clone death rate depends
on the population structure of infected cells and will vary over time as this population structure
changes. For example, a higher proportion of singletons will increase δS(t).
We assume that, in the chronic stage of infection when HTLV-1 proviral load is at equilib-
rium, the number of clones is also at equilibrium and so we have N(t) = N, S’(t) = 0, and S(t) =
PLOS COMPUTATIONAL BIOLOGY Ratio of infectious to mitotic spread in HTLV-1 persistence
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S. Letting d̂S be the average rate of clone death, we can approximate Eq (14) as













rI,Supremum will substantially overestimate infectious spread because it applies the relatively high
singleton death rate to all clones—clones with few cells become extinct more quickly than
clones with many cells. To obtain a tighter upper bound we divide clones into those that are












where nf denotes the number of clones of frequency f, i.e. the "occupancy classes". The aggre-
gate clone death rate of small clones d̂small and of large clones d̂ large will comprise a weighted
average of the death rate of clones of all sizes within that category. Because the HTLV-1 clonal
frequency distribution is heavy tailed, small clones are more numerous than large clones, and
so will make the dominant contribution to the clone death rate. Therefore the contribution








Provided fmax is sufficiently small, then d̂small (which is less than or equal to δ) can be
approximated by δ. The error incurred by this approximation decreases as fmax is reduced, and
so the infectious spread rate will be best approximated by rI;fmax for low values of fmax. Estimates
of the ratio of infectious spread to mitotic spread can be obtained by dividing rI,Supremum and
rI;fmax by the per-capita rate of mitotic spread π = 0.0316 (S1 Text) to give
RSupremum ¼ rI;Supremum=p ð20Þ
and
Rf max ¼ rI;fmax=p: ð21Þ
Modelling approach 3: Occupancy class model
Adapting a model of naïve T cell dynamics [46], we model the occupancy classes nf of HTLV-1
clones (Fig 4). We assume that the clonal structure is in equilibrium (i.e. that the number of
clones in each size class is constant) and that the probabilities of cell proliferation and death
are independent of clone size.
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Scaling so there is one event (i.e. de novo infection or mitosis) per cell per unit time we
have I + M = 1 and R: = I / M. Therefore
I ¼ R=ð1þ RÞ ð22Þ
and
M ¼ 1=ð1þ RÞ ð23Þ
where I and M are the rates of infectious and mitotic spread (scaled as above), and R is the
ratio of infectious to mitotic spread.
A clone in occupancy class f moves to class f+1 by mitosis with probability
Mfnf=N ¼ fnf=Nð1þ RÞ ð24Þ
where N is the number of infected cells. A clone in occupancy class f+1 moves down to class f
by death. Loss of cells by death is equal to the production of new cells by infection and mitosis,
which has been scaled to 1, so the death rate is 1 per unit time. Since we assume that the proba-
bility of death is independent of clone size, the probability that the one death event in unit
time occurs to a cell in size class i+1 is simply equal to the proportion of cells in size class i+1
i.e. fnf / N.
In order for the number of cells Cf in size class f (Cf = fnf) to remain constant, we require
that flow in and flow out of the occupancy class nf to be equal (Fig 4), i.e. that the number of
cells leaving occupancy class nf must be equal to those arriving from class nf-1 (via mitosis) and


























Cf   1 ð26Þ















Fig 4. Occupancy class model schematic. Singletons (clones of size 1) are produced by infectious spread (red). Proliferation (orange)
results in loss from clone size class nf and entry into size class nf + 1. Death of a cell (green) results in a clone moving from size class f to size
class nf—1.
https://doi.org/10.1371/journal.pcbi.1007470.g004
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And for the population as a whole to remain of constant size we need the gain of new clones







Rearranging (28) gives our first estimator (R1) for the ratio R from the occupancy class









Cf   1 for f ¼ 2; 3 . . .1 ð30Þ



















i.e. (30) when f = 2.



















































obtained by substituting in (31).
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(a special case of the polylogarithm function)
We have that





Rearranging for R, this provides our second estimator for the ratio of infectious to mitotic
spread, R2, from the occupancy class model.
The number of infected cells in the body is estimated from each patient’s proviral load, as
described in [10]. The proportion of infected cells that are singletons is estimated using the
DivE distribution generation algorithm, and given in S1 Table. This algorithm estimates the
relative frequencies of observed and unobserved clones from extrapolated rarefaction curves.
Further details are given in [10].
We have outlined three methods: a deterministic and stochastic hybrid model of individual
HTLV-1 clones over time; a greatly simplified model to approximate the upper bound of the
infectious spread rate; and a model of clone occupancy classes. This final method yields two
estimators.
Results
HTLV-1 clonal diversity estimates
We previously estimated HTLV-1 clonal diversity (the number of unique clones) from
sequence data in 11 subjects with non-malignant HTLV-1 infection (either asymptomatic car-
riers, HTLV-1-associated uveitis patients or those with HAM/TSP). These estimates were
obtained by measuring diversity in the nine blood samples per person (three at each of three
time points) and then applying our recently developed method of estimating clonal diversity
by extrapolation from the sample to the whole body [10] (Table 1, S1 Table and S1 Fig).









clones in body) [10]
Infectious spread rate rI (d-1)
[Mean, (Lower–Upper)†, standard
deviation within patient replicate
samples]
Ratio of infectious to mitotic spread
[Mean, (Lower–Upper)†, standard





1 (AC) 417 50666 1.0e-09, (5.9e-10–1.4e-09), 2.6e-10 3.3e-08, (1.9e-08–4.4e-08), 8.3e-9 149, (101–191)
2 (UV) 133 19025 1.1e-09, (4.8e-10–1.6e-09), 3.5e-10 3.5e-08, (1.5e-08–5.0e-08), 1.1e-8 51, (25–67)
3 (HAM) 320 59908 1.7e-09, (1.2e-09–2.1e-09), 3.0e-10 5.2e-08, (3.9e-08–6.8e-08), 9.6e-9 181, (130–243)
4 (HAM) 920 36840 2.8e-10, (2.1e-10–3.7e-10), 5.4e-11 8.8e-09, (6.8e-09–1.2e-08), 1.7-.9 89, (68–113)
5 (HAM) 160 16485 7.8e-10, (5.2e-10–1.0e-09), 1.9e-10 2.5e-08, (1.6e-08–3.3e-08), 6.0e-9 43, (33–58)
6 (HAM) 187 15906 6.1e-10, (3.4e-10–9.5e-10), 2.3e-10 1.9e-08, (1.1e-08–3.0e-08), 7.3e-9 39, (19–57)
7 (HAM) 2077 152180 5.9e-10, (4.9e-10–6.8e-10), 6.7e-11 1.9e-08, (1.5e-08–2.2e-08), 2.1e-9 428, (346–496)
8 (HAM) 1753 52246 2.1e-10, (1.6e-10–3.3e-10), 5.9e-11 6.8e-09, (4.9e-09–1.0e-08), 1.9e-9 128, (82–178)
9 (HAM) 1827 142032 7.3e-10, (5.3e-10–1.1e-09), 2.2e-10 2.3e-08, (1.7e-08–3.4e-08), 6.9e-9 456, (303–671)
10 (HAM) 813 68897 6.8e-10, (6.1e-10–7.6e-10), 6.4e-11 2.2e-08, (1.9e-08–2.4e-08), 2.0e-9 196, (157–249)
11 (HAM) 690 59145 7.6e-10, (4.2e-10–1.6e-09), 4.1e-10 2.4e-08, (1.3e-08–4.9e-08), 1.3e-8 161, (118–234)
Mean 845 61212 7.7e-10 d-1 2.4e-8 175
� Mean value of nine replicate samples for each patient (see methods)
† Lower and Upper denote the range of estimates from nine hybrid model fits from each subject.
‡ Disease status: AC = asymptomatic carrier. UV = uveitis (non-HAM/TSP); HAM = HAM/TSP
https://doi.org/10.1371/journal.pcbi.1007470.t001
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We tested our assumption that the number of clones is at equilibrium in the chronic phase
of infection, where HTLV-1 proviral load is at equilibrium. Using a two-tailed binomial test,
we found little evidence that this change was significantly different from zero (p = 1 for
observed and p = 0.07 for estimated). We further used linear regression to estimate the net
change per day in the observed and estimated number of clones in each subject. This net
change was 0.01 (95% CI -0.07–0.09) clones per day (i.e. 1 clone every 100 days) and -2.50
(-5.94–0.93) clones per day in the observed and estimated number of clones respectively; in
each case the confidence interval spans zero. We therefore make the approximation that
HTLV-1 clonal diversity remains unchanged in the chronic phase of infection, after the provi-
ral load has reached steady state.
It is important to note that this assumption requires some infectious spread to replenish
dying clones. However, if there were no infectious spread, and given the cell death rate δ
(0.0316 d-1) and the estimated number of singletons n1 (5.5 × 102–2.3 × 104, (S1 Table)), we
would expect approximately n1 × δ clones to be lost every day, i.e. an average of 172 (between
18 and 718). This number is vastly more than we estimate. Furthermore, this logic is conserva-
tive as it ignores the number of clones with two cells, number of clones with three cells, etc. that
will die. Finally, if there was no replacement of clones through infectious spread during chronic
infection, we would expect the estimates of clonal diversity to decline within patients over time.
Modelling approach 1: Full simulation hybrid model
We model within-host HTLV-1 persistence by considering HTLV-1-infected clones sepa-
rately. Large clones are modelled deterministically using a system of ordinary differential equa-
tions. Smaller clones are modelled stochastically by solving the chemical master equation (Eqs
(9) and (10)) that considers the frequency of each clone as a random variable governed by a
birth-death process (Fig 2B). The per-capita rate of infectious spread and the expected number
of infected cells are then combined to model the birth of new clones (Eq (11)), and the extinc-
tion probability of each clone is used to calculate the expected clone death (Eq (12)). The birth
and death (extinction) of clones provide an estimate of the number of clones at equilibrium
(Eq (13), Fig 2C), and it is this value that is fitted to our estimates of HTLV-1 clonal diversity,
to infer the per-capita rate of infectious spread (Fig 2D).
The hybrid model was fitted for each subject, for all samples at each time point, providing
an estimate of the infectious spread rate in each case (Table 1, S3 Table). These nine estimates
per patient were averaged to calculate the mean rate for each individual. Between individuals,
the mean estimated rate of infectious spread was 7.7 × 10−10 per day, ranging from 2.1 × 10−10
to 1.7 × 10−9 per day (Table 1). Given an estimate of the rate of mitotic spread of 3.2 × 10−2 per
day (Table 2), our infectious spread estimates imply an average ratio of infectious to mitotic




rI daily per-capita rate of infectious spread (de novo infection) Fitted for each patient [Methods] See Table 1








K Density dependency parameter. Infected cell proliferation rates are half maximal when
number of infected cells N(t) = K
Derived from [35] (supplementary
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spread of 2.4 × 10−8 (6.6 × 10−9–5.3 × 10−8), i.e. varying by almost an order of magnitude
(Table 1, Fig 5A).
While the per-capita infectious spread rate is very low, it translates to an average of 175
(range 39–456) new clones created per day (Fig 5B). Therefore the hybrid model predicts that
infectious spread is not limited to initial infection, but persists at a low level throughout the
chronic phase. Over a 10-year period, this amounts to an average of 6.4 × 105 clones that are
created and destroyed (1.4 × 105–1.7 × 106). As each clone will integrate in a new genomic site,
low but sustained levels of infectious spread could be an alternative mechanism by which
chronic infection develops into malignancy.
Within individuals the standard deviation between samples in the infectious spread rate
was relatively small, with an average of 2 × 10−10 (5.4 × 10−11–4.1 × 10−10) (Table 1). Estimates
of the per-capita infectious spread rate were not found to correlate with either proviral load or
with the estimated diversity during the chronic phase (this may be due to our 11 patients pro-
viding insufficient power). However, unsurprisingly, the estimated number of new clones per
day was correlated with both proviral load (R2 = 0.62) and strongly correlated with the esti-
mated diversity (R2 = 0.99) (S2 Fig).
Sensitivity analyses of hybrid model
We investigated the sensitivity of our results to: i) choice of threshold frequency F (above and
below which clones are respectively modelled deterministically and stochastically); ii) choice
of time step; iii) use of hybrid deterministic and stochastic model (as opposed to a purely sto-
chastic model); and iv) choice of proliferation and death parameters.
Originally our threshold value of F was set to equal 100. However, the extinction probability
of clones of size 100 over a duration of tDur = 3133 days (S2 Text) duration was 0.37. We were
therefore concerned that excluding such clones would bias the estimates of the infectious
Fig 5. Ratio of infectious spread to mitotic spread and number of new clones per day, by patient and estimator. A Ratio of infectious spread to mitotic spread.
B Number of new clones generated per day. Values of both the ratio and number of new clones are derived from estimators of infectious spread. In each plot, red
crosses and bars respectively denote point estimates and the range from the nine estimates for each subject from the hybrid model. Upper bound approximations
from rI,Supremum (green triangles) are shown, together with tighter upper bounds from rI;fmax (coloured circles) for multiple values of fmax between 1 and 1000. Lighter
colours denote higher values of fmax. Hybrid model point estimates are very close to the estimates obtained for fmax = 1 (lowest circles). Estimates plotted on
logarithmic scale.
https://doi.org/10.1371/journal.pcbi.1007470.g005
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spread rate and therefore the ratio, and so re-fitted our model with F = 460. This value is the
minimum clone frequency for which the extinction probability is less than 1%, given our
parameters of infected cell growth, death, and density dependency (S3 Fig, S2 Text). The esti-
mates of infectious spread from the hybrid model are almost identical whether we assume
F = 100 or F = 460. We present the F = 460 estimates, as the most accurate description of the
system would to consider all clones stochastically.
We find that a timestep of h = 1 day results in negligible splitting errors (S4 Fig), and that
using a hybrid deterministic and stochastic system gives an appropriate approximation of our
stochastic process (S5 Fig).
We investigated the sensitivity of the hybrid to proliferation and death rates. We fitted the
model again, assuming these rates were halved (to give π� = δ = 0.0158) or doubled (to give
π� = δ = 0.0632), while still modelling proviral load at equilibrium. We find that the ratio of
infectious spread to mitotic spread is robust to these different values, giving almost identical
results. However, the infectious spread rate rI, and therefore the number of new clones per day
are sensitive to proliferation, death, and density-dependency parameters π, δ and K (S3 Table,
S6 Fig), although results are similar. When rates were halved and doubled, the average number
of new clones per day was respectively 89 (20–234) and 341 (77–885).
Although the population is still at equilibrium, higher proliferation and death rates cause
the birth-death process for each clone to behave more “erratically”, thus increasing the proba-
bility of clone extinction, and the ensuing higher clone death must be met with additional
infectious spread.
Modelling approach 2: Upper bound approximation
Upper bounds of the infectious spread rate (rI,Supremum) were estimated for each subject using Eq
(17), by substituting inputs of HTLV-1 clonal diversity estimates (Table 1, S1 Table) and an esti-
mate of δ = 0.0316 infected cell death a day, and an estimate of the total number of infected cells
N (derived from the proviral load, as detailed in [10]). For each individual we averaged across all
samples and across all time points. Estimated values of the rate ranged between individuals from
2.8 × 10−9 to 1.7 × 10−8 per infected cell per day, and thus (given a per-capita rate of mitotic
spread of 0.0316 cells per day) estimates of the ratio RSupremum ranged between 8.7 × 10−8 and
5.5 × 10−7 (Fig 5A). The estimated number of new clones per day using rI,Supremum are unsurpris-
ingly much larger than those of the hybrid, ranging from 516 to 4804, i.e. approximately an
order of magnitude higher (Fig 5B).
We further estimated the more restrictive upper bounds of the ratio Rfmax from Eq (21) for
multiple fmax values between 1 and 1000 (Fig 5A). These estimates assume that the cell death
rate applies to clones with frequencies less than or equal to fmax, and that larger clones do not
contribute to the rate.
The hybrid estimates always fall below the estimated supremum and are very close to the
estimates provided by for fmax = 1 (Fig 5, S6 Fig). Since it is likely that the upper bound approx-
imation will give more accurate estimates for lower values of fmax, this result demonstrates the
consistency of estimates produced between the hybrid and the upper bound approximation,
and further implies that the number of singletons is the dominant factor in the extent of infec-
tious spread. We estimate that singletons constitute between 6% and 12% of clones (S1 Table).
Modelling approach 3: Occupancy class model
The results from the hybrid model indicate a very low ratio of infectious to mitotic spread. The
hybrid benefits from treating small clones stochastically and from the inclusion of known
experimental details of HTLV-1 infection and spread. However, it remained possible that
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these very low estimates of the ratio resulted from incorrect model or parameter assumptions.
To test the robustness of our estimate of the ratio to changes in model and parameter assump-
tions, we adapted a simple deterministic model of HTLV-1 clonal dynamics and occupancy
classes and used this to produce two alternative estimators of the ratio of infectious to mitotic
spread.
The occupancy class model is based on a model of naïve T cell dynamics developed by de
Greef et al [46]. It assumes that clonal dynamics are deterministic, that the clonal structure is
in equilibrium and that the probabilities of cell proliferation and death are independent of
clone size. The model yields two estimators of the ratio of infectious to mitotic spread. The





where p is the proportion of cells that are singletons.
The second estimator (referred to as R2) depends on species richness.





where N is the number of infected cells (see Methods for derivation of both expressions).
Across the 99 estimates (11 subjects, 3 time points, 3 replicates) both estimators, R1 and R2,
are strongly positively correlated with the estimate of the ratio produced by the hybrid model
(P = 1 × 10−135 and P = 6 × 10−87 respectively, Pearson correlation) and agree well numerically,
being of the same order of magnitude and, if anything tending to be even smaller (hybrid
median = 2.0 × 10−8, hybrid LQ = 1.4 × 10−8, hybrid UQ = 3.0 × 10−8; R1 median = 2.0 × 10−8,
R1 LQ = 1.4 × 10−8, R1 UQ = 3.0 × 10−8; R2 median = 1.3 × 10−8, R2 LQ = 1.0 × 10−8, R2
UQ = 1.9 × 10−8) (Fig 6).
Finally, we applied the second estimator from the occupancy class model (R2) to the Chao1
estimator of clonal diversity (rather than the DivE estimate used up to this point). The Chao1
estimator gives much lower diversity estimates, and so unsurprisingly yields considerably
smaller estimates of the infectious to mitotic spread ratio (median = 7.3 × 10−10,
LQ = 4.7 × 10−10, UQ = 1.0 × 10−9).
We conclude that the low estimates of the infectious to mitotic spread are not the product
of implicit assumptions in the hybrid model or incorrect parameter choice. Inaccurate esti-
mates of the clonal diversity may play a significant role but calculations using an alternative,
widely used estimator provided even smaller estimates of clonal diversity, and therefore yield
an even lower ratio. The lower estimates of the ratio from Chao estimator are driven by its
lower diversity estimates. However we found previously that these diversity estimates were
unrealistically low, in that they predicted fewer clones than were observed in additional blood
samples taken from the same subject at the same time, whereas DivE did not [10]. Our esti-
mates of ongoing infectious spread during chronic infection are therefore more likely to be an
underestimate than an overestimate.
Discussion
The relative contribution of infectious and mitotic spread to HTLV-1 viral persistence has not
previously been estimated, and this has been a long-standing problem in the field. For many
years, it was believed that the virus persisted solely by oligoclonal proliferation of latently
infected cells, and that infectious spread contributed little if anything to persistence. However,
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three observations have brought this belief into question. First, the strong, persistently acti-
vated host T-cell response to HTLV-1 implied that the virus is not latent but is frequently
expressed in vivo. Second, high-throughput analysis revealed that a typical host carries
between 104 and 105 clones, not ~100 clones as was previously believed. Third, treatment with
Fig 6. Comparison of estimates of ratio of infectious to mitotic spread from the hybrid model (method 1) and the occupancy class model (method 3).
(Top left) Estimate of ratio from hybrid model plotted against first estimate from occupancy class model (R1). Red line is line of best fit, black line is line of
equality. (Top right) Estimate of ratio from hybrid model plotted against second estimate from occupancy class model (R2). Red line is line of best fit, black
line is line of equality. (Bottom left) Estimate of ratio between hybrid model and first estimate from occupancy class model (R1). Black line denotes the
median. (Bottom right) Estimate of ratio between hybrid model and second estimate from occupancy class model (R2). Black line denotes the median.
https://doi.org/10.1371/journal.pcbi.1007470.g006
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the antiretroviral therapy lamivudine temporarily but substantially reduced the proviral load
of a patient with HAM/TSP. These observations raise the question: what is the contribution of
infectious spread to the persistence of HTLV-1 in the host after initial infection?
In this study, we used three different strategies to estimate the ratio of infectious to mitotic
spread during the chronic phase of infection. We first developed a deterministic and stochastic
hybrid model of within-host HTLV-1 dynamics, and fitted this model to clonal diversity esti-
mates derived from experimental data. We then derived an estimate of the upper bound of the
ratio by using a highly simplified model where individual clones are not considered. Finally,
we adapted a model of naïve T cell repertoires that models clone occupancy classes. We found
broad agreement between the estimates of the ratio obtained using all three methods; and each
method implied the existence of ongoing infectious spread during chronic infection, after the
HTLV-1 proviral load has reached steady state.
We found no evidence that HTLV-1 clonal diversity either increases or decreases over time,
and we therefore assumed that the number of HTLV-1 clones is in equilibrium during chronic
infection. It is important to note that this assumption necessitates some infectious spread by
design. However, the estimated number of clones changes far less over time than would be
expected if there were no infectious spread, given the cell death rate and proportion of clones
that are singletons, and so we believe this assumption is justified.
While the ratio of infectious to mitotic spread during the chronic phase is very small
(~2 × 10−8), it equates to ~102 new clones every day. That is, approximately 100 new HTLV-
1-infected T cell clones appear every day by infectious spread. Over a 10-year period, this
would result in an average of 6.4 × 105 clones created and subsequently destroyed. Further,
while the estimated rate of infectious spread represents a negligible contribution to HTLV-1
proviral load, the constant creation of new clones will increase the risk of malignant transfor-
mation, because this risk depends in part on the proviral integration site [21]. Malignancy
could arise not only from accumulated mutations in a long-lived clone (where only mitotic
spread is relevant), but also from frequent proviral integration (where only infectious spread is
relevant).
High HTLV-1 proviral load increases both clonal diversity [47] and risk of ATL [7]. How-
ever, it is unknown whether the increased clonal diversity (caused by infectious spread) is a
mechanism for this higher risk of malignancy, or whether it is a separate by-product of high
proviral load. Ongoing infectious spread during chronic infection would be consistent with
the hypothesis that higher infectious spread increases the risk of malignant transformation. If
this is the case, then anti-retroviral therapy could reduce the risk of ATL in patients who have
entered their chronic phase, not by sustainably suppressing proviral load, but by limiting pro-
viral integration; this therapy would need to be continued for many years before its impact was
evident.
It is important to note that the different methods we use are not independent. First, they all
use our clonal diversity estimates as an input (see section below). Second, they all assume equi-
librium clonal diversity. However, they do differ in a number of respects. The upper bound
approximation is independent of the parameters F, π and K and makes no assumptions about
the clonal structure or the density dependence of infected cell proliferation. The R1 estimator
from the occupancy class model depends only on the proportion of singletons and so is inde-
pendent of all the parameters (F, π, δ and K), assumptions about density dependence of prolif-
eration, and indeed the estimated clonal structure beyond the number of singletons. Similarly
the R2 estimator from the occupancy class model is also independent of F, π, δ and K as well as
proliferation assumptions. While the hybrid model is our most detailed simulation of HTLV-1
within-host dynamics, it is mathematically and computationally complex and requires signifi-
cant runtime. Because the estimates from all three methods are largely consistent, our analysis
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indicates that the latter two methods provide good approximations of the rate of infectious
spread and the ratio of infectious to mitotic spread.
The most likely source of error in our estimates of the ratio of infectious to mitotic spread
lies in the estimation of clonal diversity. Two factors argue against a serious error. First, esti-
mates based on two different quantities (the number of clones and the proportion of infected
cells that are singletons) give very similar estimates of the ratio. Second, diversity estimates
from DivE are far more plausible than those from other widely used estimators of species rich-
ness: these other estimators produced demonstrably false estimates that were lower than the
diversity observed by combining blood independent samples drawn at the same time from the
same patient. [10]. It remains possible that we have underestimated clonal diversity, although
if so then our conclusion of ongoing infectious spread during chronic infection would only be
strengthened.
A much smaller source of potential error lies in using the number of clones to quantify
infectious spread. If the virus repeatedly integrates in the same genomic site, then the number
of unique genomic sites would be less than the number of true clones, and hence both the
infectious spread rate and the ratio would be underestimated. However, hotspots of HTLV-1
integration have not been observed [9], and so such repeat infection would not substantially
alter our estimate. Assuming the provirus does not efficiently integrate into heterochromatin,
which represents ~2/3 of the human genome, then only one third of the ~3 × 109 base pairs of
the human genome have the potential for proviral integration. The probability of repeated pro-
viral integration is then the number of existing integration sites divided by the number of
potential integration sites. Given the estimated number of clones is of the order of 105, this
probability is approximately 105/109 = 10−4. Therefore, any error in using the number of clones
to quantify infectious spread infectious spread is very small.
It seems surprising that, during initial infection, the virus could establish a stable population
of infected T cell clones with such a low rate of infectious spread. However, these low rates of
infectious spread are measured in the chronic phase of infection, when the strong host cyto-
toxic response kills HTLV-1-expressing cells, which probably reduces efficient infectious
transmission and favours mitotic transmission. During the early phase of infection, before the
establishment of an adaptive immune response, the contribution of infectious spread is likely
to be substantially higher than during chronic infection. It would be interesting to model the
dynamics of early infection, in particular to investigate the rate required to establish a stable
population of infected T cell clones. Modelling early infection would violate the assumption of
equilibrium, and thus would void many of the simplifying assumptions that makes our model
tractable (e.g. our ability to model clones independently and so avoid an exponential increase
in complexity). However, given sufficient computational power, this analysis would be
possible.
Another extension of each of the methods presented might be to include variable prolifera-
tion rates for each clone, which would refine estimates of the infectious spread rate and ratio
of infectious spread to mitotic spread. Because clones proliferate in response to antigen, our
assumption of a single per-capita infected cell proliferation rate is a simplifying approximation.
If larger clones are larger in part because they proliferate faster than small clones, then small
clones will die at a faster rate, which would likely require more infectious spread to maintain
equilibrium of clonal diversity.
The methods described here have potential applications in other fields, for example in
modelling the human T cell receptor (TCR) repertoire. The mechanisms by which the immune
system is reconstituted after immune suppression or transplantation are poorly understood.
Drawing parallels between immune reconstitution and HTLV-1 infectious and mitotic spread,
the present approach could be applied to investigate the extent to which reconstitution occurs
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either through the generation of new TCR clonotypes, or through the expansion of existing
clonotypes. In HIV-1 infection, the approach could be used to quantify the ratio of infectious
to mitotic spread in the absence of treatment and in the latent reservoir remaining following
treatment.
In summary, we develop three methods, which have the potential to be applied to a range of
areas, and use them to quantify the role of de novo infection in HTLV-1 persistence during
chronic infection. We find that on average 5 x 109 new infected cells are produced every day;
of these the vast majority (>99.9%) will arise from division of an existing infected cell and will
thus have the same proviral integration site as their mother cell, but a small minority (about
175 cells per day) will arise from infectious transmission and will contain a novel proviral inte-
gration site. These estimates suggest that ongoing infectious spread may be a mechanism for
malignant transformation that treatment with antiretroviral drugs may suppress.
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(PDF)
S3 Text. Further hybrid model sensitivity analysis.
(PDF)
S1 Table. Patient sample characteristics and diversity estimates.
(PDF)
S2 Table. Notation used in models of HTLV-1 within host persistence.
(PDF)
S3 Table. Hybrid model sensitivity to proliferation and death rates.
(PDF)
S1 Fig. Observed and estimated diversity (number of HTLV-1+ clones) over time by
patient. Estimated diversity is shown in blue (left hand y-axes) and observed diversity is
shown in red (right-hand y-axes).
(TIF)
S2 Fig. Correlations between per-capita infectious spread rate, daily number of new clones,
estimated clonal diversity and HTLV-1 proviral load. Infectious spread rate is not correlated
with either the estimated diversity (A, R2 = 0.0069) during the chronic phase or proviral load
(B, R2 = 0.28). However, unsurprisingly, the estimated number of new clones per day was
strongly correlated with both the estimated diversity (C, R2 = 0.99) during the chronic phase
or proviral load (D, R2 = 0.62) and proviral load.
(TIF)
S3 Fig. Choice of stochastic threshold frequency F and individual clone state space upper
limit τ values for hybrid model. A Extinction probabilities by clone starting frequency (red)
at tDur = 3133 days (given our values of infected cell proliferation and death parameters). Sto-
chastic threshold frequency F = 460 (green) is chosen to be the minimum starting frequency
such that a clone has less than a 1% (black line) chance of extinction. B Probability distribution
of a clone at tDur = 3133 days given starting frequency F = 460. The upper limit τ (blue) is cho-
sen so that this probability distribution is not significantly distorted.
(TIF)
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S4 Fig. Effect of hybrid time step length h. Expected diversity S(tDur) at given duration
(tDur = 600 days) (first row); minimum diversity predicted throughout given duration (second
row); and the number of infected cells N(tDur) predicted at tDur (third row), plotted against
time step length h for three parameter sets: θG = {rI = 2 × 10−11, π� = 0.0316, δ = 0.5 � π�} (left
column—“growth”); θE = {rI = 2 × 10−11, π� = 0.0316, δ = π�} (middle column—“equilibrium”);
θD = {rI = 2 × 10−11, π� = 0.0316, δ = 2 � π�} (right column—“death”) for an example patient
data set. Note that y-axes are split so that time step differences are visible. Time step effects are
negligible for each observable.
(TIF)
S5 Fig. Comparison of pure stochastic and hybrid deterministic and stochastic model on
reduced system. Reduced system omits all clones of size greater than 460 cells. For each
patient, both the estimated number of clones over time and the fitted values of rI are very simi-
lar between the pure stochastic and the deterministic/stochastic hybrid model.
(TIF)
S6 Fig. Ratio of infectious spread to mitotic spread and number of new clones per day, by
patient, estimator, and parameter choice. As per Fig 5. A, C Ratio of infectious spread to
mitotic spread. B, D Number of new clones generated per day. A, B assume π� = δ = 0.0158,
half the value in our main analysis. C, D assume π� = δ = 0.0632, twice the value in our main
analysis. Estimates of the ratio of infectious spread to mitotic spread are almost identical. The
infectious spread rate and therefore the number of new clones per day are sensitive to choice
of proliferation and death parameters, although values are comparable. Upper bound approxi-
mations for fmax = 1 again match the more-detailed hybrid model.
(TIF)
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